Studies on hemostasis in COVID‐19 deserve careful reporting of the laboratory methods, their significance, and their limitations
暂无分享,去创建一个
P. Fontana | T. Lecompte | I. Gouin-Thibault | F. Mullier | J. Douxfils | M. Hardy | M. Bareille | S. Lessire
[1] G. Lippi,et al. Management of the thrombotic risk associated with COVID-19: guidance for the hemostasis laboratory , 2020, Thrombosis Journal.
[2] P. Myles,et al. Fibrinolysis and COVID‐19: A tale of two sites? , 2020, Journal of Thrombosis and Haemostasis.
[3] L. Argaud,et al. Hypofibrinolytic state and high thrombin generation may play a major role in SARS‐COV2 associated thrombosis , 2020, Journal of Thrombosis and Haemostasis.
[4] N. Guzzetta,et al. Not just small adults: Considering the impact of developmental hemostasis on neonatal extracorporeal circulation , 2020, Journal of thrombosis and haemostasis : JTH.
[5] F. V. D. van der Meer,et al. Quality performance for indirect Xa inhibitor monitoring in patients using international external quality data , 2020, Clinical chemistry and laboratory medicine.
[6] M. Ranucci,et al. Sensitivity of Viscoelastic Tests to Platelet Function , 2020, Journal of clinical medicine.
[7] E. Weiss,et al. New insights into neonatal coagulation: normal clot formation despite lower intra-clot thrombin levels , 2019, Pediatric Research.
[8] M. Siepe,et al. Acquired von Willebrand syndrome in paediatric patients during mechanical circulatory support. , 2019, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[9] J. Dogné,et al. Assessment of the analytical performances and sample stability on ST Genesia system using the STG‐DrugScreen application , 2019, Journal of thrombosis and haemostasis : JTH.
[10] B. Zieger,et al. Acquired von Willebrand syndrome and impaired platelet function during venovenous extracorporeal membrane oxygenation: Rapid onset and fast recovery. , 2018, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[11] J. Thachil,et al. A re‐evaluation of the D‐dimer cut‐off value for making a diagnosis according to the ISTH overt‐DIC diagnostic criteria: communication from the SSC of the ISTH , 2018, Journal of thrombosis and haemostasis : JTH.
[12] R. van Oerle,et al. Validation of a modified thromboelastometry approach to detect changes in fibrinolytic activity , 2016, Thrombosis Journal.
[13] E. Duncan,et al. Evaluation of pre-analytical variables in a commercial thrombin generation assay. , 2014, Thrombosis research.
[14] B. Rinner,et al. Microparticles in newborn cord blood: slight elevation after normal delivery. , 2011, Thrombosis research.
[15] H. Köfeler,et al. Phospholipid content, expression and support of thrombin generation of neonatal platelets , 2008, Acta paediatrica.
[16] D. Atsma,et al. Development of a new test for the global fibrinolytic capacity in whole blood , 2007, Journal of thrombosis and haemostasis : JTH.
[17] W. Muntean,et al. Low tissue factor pathway inhibitor (TFPI) together with low antithrombin allows sufficient thrombin generation in neonates , 2003, Journal of thrombosis and haemostasis : JTH.
[18] P. Powers,et al. Development of the human coagulation system in the full-term infant. , 1987, Blood.